Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Transitional Cell × Water × Clear all

Sponsor

Conditions

Stomatitis 2 Neoplasms 2 Mucositis 2 Colorectal Neoplasms 2 Vulvodynia 1 Pain 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Mobility Limitation 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Dyspareunia 1 Disease 1 Carcinoma, Non-Small-Cell Lung 1 Cancer Pain 1 Breast Neoplasms 1

Interventions

pembrolizumab 21 atezolizumab 12 Gemcitabine 12 Nivolumab 10 Cisplatin 10 Docetaxel 8 Carboplatin 8 Mitomycin 5 avelumab 4 Ipilimumab 4 pemigatinib 3 epacadostat 3 Paclitaxel 3 Bevacizumab 3 vofatamab 2 lenvatinib 2 enfortumab vedotin 2 cabozantinib 2 cabazitaxel 2 bempegaldesleukin 2 Standard of Care 2 Rogaratinib 2 Ramucirumab 2 Platinum 2 Pemetrexed 2 Everolimus 2 Biopsy 2 B701 protein, Human herpesvirus 6 2 Albumin-Bound Paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡